文献速递重症综合管理与镇静镇痛心脑血管急症

左心室减压对心源性休克患者急性脑损伤的影响:体外生命支持组织登记分析

Impact of Left Ventricular Venting on Acute Brain Injury in Patients With Cardiogenic Shock: An Extracorporeal Life Support Organization Registry Analysis.
PubMed 文献 · Crit Care Med · 2025-10-17
一句话结论接受外周VA-ECMO的心源性休克患者中,左心室减压与急性脑损伤风险升高相关(aOR 1.67),但与住院死亡率无关。

该回顾性观察性队列研究基于体外生命支持组织登记数据,纳入2013—2024年因心源性休克接受外周静脉-动脉体外膜氧合(VA-ECMO)的成人患者13,276例,其中1,456例(11.0%)接受左心室减压(65.5%为经皮微轴流泵,29.9%为主动脉内球囊反搏),525例(4.0%)发生急性脑损伤。多变量回归显示,左心室减压与急性脑损伤风险升高相关(aOR 1.67;95%CI 1.22-2.26;P=0.001),但与住院死亡率无关(aOR 1.07;95%CI 0.90-1.27;P=0.45)。倾向性评分匹配后,主动脉内球囊反搏与经皮微轴流泵两组急性脑损伤风险(aOR 1.35;95%CI 0.69-2.71;P=0.39)及死亡率(aOR 0.88;95%CI 0.58-1.31;P=0.52)均无显著差异。

要点

  • 在13,276例外周VA-ECMO心源性休克成人中,1,456例(11.0%)接受左心室减压,525例(4.0%)发生急性脑损伤。
  • 左心室减压组较未减压组急性脑损伤风险升高(aOR 1.67;95%CI 1.22-2.26;P=0.001),住院死亡率无差异(aOR 1.07;95%CI 0.90-1.27;P=0.45)。
  • 倾向性评分匹配后,主动脉内球囊反搏(n=231)与经皮微轴流泵(n=231)相比,急性脑损伤风险无显著差异(aOR 1.35;95%CI 0.69-2.71;P=0.39)。
  • 匹配队列中主动脉内球囊反搏与经皮微轴流泵的住院死亡率亦无显著差异(aOR 0.88;95%CI 0.58-1.31;P=0.52)。

适用人群与场景

  • 成人(中位年龄58.2岁,69.9%为男性)因心源性休克接受外周静脉-动脉体外膜氧合(VA-ECMO)的患者,数据来自体外生命支持组织登记,时间跨度2013—2024年。

诊断标准与关键阈值

  • 急性脑损伤定义为缺氧缺血性脑损伤、缺血性卒中或颅内出血。

研究设计与关键结果

  • 回顾性观察性队列研究,基于体外生命支持组织登记,纳入13,276例成人外周VA-ECMO心源性休克患者,其中1,456例(11.0%)接受左心室减压(65.5%为经皮微轴流泵,29.9%为主动脉内球囊反搏),525例(4.0%)发生急性脑损伤。
  • 多变量logistic回归显示,左心室减压组较未减压组急性脑损伤风险升高(aOR 1.67;95%CI 1.22-2.26;P=0.001),住院死亡率无差异(aOR 1.07;95%CI 0.90-1.27;P=0.45)。
  • 倾向性评分匹配队列中,主动脉内球囊反搏(n=231)与经皮微轴流泵(n=231)比较,急性脑损伤风险无显著差异(aOR 1.35;95%CI 0.69-2.71;P=0.39),住院死亡率无显著差异(aOR 0.88;95%CI 0.58-1.31;P=0.52)。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在接受外周VA-ECMO的心源性休克患者中,左心室减压与急性脑损伤风险升高相关,但与死亡率无关;主动脉内球囊反搏与经皮微轴流泵两种减压策略的急性脑损伤风险和死亡率无差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: While left ventricular (LV) venting reduces LV distension in cardiogenic shock patients on venoarterial extracorporeal membrane oxygenation (ECMO), it may also amplify risk of acute brain injury (ABI). We investigated the hypothesis that LV venting is associated with increased risk of ABI. We also compared ABI risk of the two most common LV venting strategies, percutaneous microaxial flow pump (mAFP) and intra-aortic balloon pump (IABP).

DESIGN: Retrospective observational cohort study.

SETTING: The Extracorporeal Life Support Organization registry.

PATIENTS: Adult patients on peripheral venoarterial ECMO for cardiogenic shock (2013-2024).

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: ABI was defined as hypoxic-ischemic brain injury, ischemic stroke, or intracranial hemorrhage. Secondary outcome was hospital mortality. We compared no LV venting with: 1) LV venting, 2) mAFP, and 3) IABP using multivariable logistic regression. To compare ABI risk of mAFP vs. IABP, propensity-score matching was performed. Of 13,276 patients (median age = 58.2, 69.9% male), 1,456 (11.0%) received LV venting (65.5% mAFP and 29.9% IABP), and 525 (4.0%) had ABI. After multivariable regression, LV-vented patients had increased odds of ABI (adjusted odds ratio [aOR], 1.67; 95% CI, 1.22-2.26; p = 0.001) but no difference in mortality (aOR, 1.07; 95% CI, 0.90-1.27; p = 0.45) compared with non-LV-vented patients. In the propensity-matched cohort of IABP ( n = 231) vs. mAFP ( n = 231) patients, there was no significant difference in odds of ABI (aOR, 1.35; 95% CI, 0.69-2.71; p = 0.39) or mortality (aOR, 0.88; 95% CI, 0.58-1.31; p = 0.52).

CONCLUSIONS: LV venting was associated with increased odds of ABI but not mortality in patients receiving peripheral venoarterial ECMO for cardiogenic shock. There was no difference in odds of ABI or mortality for IABP vs. mAFP patients.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Feng SN, Liu WL, Kang JK, et al. Impact of Left Ventricular Venting on Acute Brain Injury in Patients With Cardiogenic Shock: An Extracorporeal Life Support Organization Registry Analysis. Crit Care Med. 2025. PMID: 41104911. doi:10.1097/CCM.0000000000006897

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。